Search Results 1931-1940 of 21357 for anti-TNF drugs

  1. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

    ... anti-CD38-Duostatin 5.2 antibody-drug conjugate (ADC) for the treatment of relapsed or refractory systemic AL amyloidosis. The patients that will be treated ...

  2. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

    paclitaxel alone in patients with biliary tract cancers (BTC) who have received one systemic therapy for advanced disease, as measured by Overall Response Rate ...

  3. Ritonavir (Oral Route) Proper Use - Mayo Clinic

    Ritonavir must be taken with other medicines that are used to treat HIV infection. Take all of the medicines your doctor has prescribed at the right time of day ...

  4. Metoprolol (Oral Route) Precautions - Mayo Clinic

    Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines ...

  5. Chlordiazepoxide And Clidinium (Oral Route) Description and Brand Names - Mayo Clinic

    Chlordiazepoxide and clidinium combination is used in combination with other medicines to treat stomach or bowel problems including peptic ulcers, irritable ...

  6. Publications - Jonathan A. Leighton, M.D. - Mayo Clinic

    Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14; 13 (8):1036-1043

  7. Levothyroxine (Oral Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. This medicine will need to be taken for the rest of your life or your child's ...

  8. Sulfamethoxazole And Trimethoprim (Oral Route) Proper Use - Mayo Clinic

    For treatment of Pneumocystis jiroveci pneumonia or Pneumocystis carinii pneumonia (PCP):. Adults and children 2 months of age and older—Dose is based on body ...

  9. A Study to Evaluate the Effectiveness of VERIS CMV Assay to Measure Cytomegalovirus (CMV) as an Aid for Monitoring the Response of the Virus to Therapy - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of the VERIS CMV Assay as an aid in the management of anti-CMV treatment for solid organ ...

  10. Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... 6-month wash-out of prior anti-PD1/PDL-1 therapy. Exclusion Criteria ...